Fredun Pharmaceuticals Declares Un-Audited Q2 FY27 Results

Fredun Pharmaceuticals Ltd announced its un-audited financial results for the Quarter and Half-Year Ended September 30, 2026. The Board of Directors also approved an application to the National Stock Exchange (NSE) for listing and trading of the company's equity shares. The trading window for insiders was closed from October 1, 2026, until 48 hours after the board meeting's outcome declaration. The board meeting was held on November 5, 2026, commencing at 10:00 a.m. and concluding at 11:10 a.m.